Current development of the roles of TRPV1 in management of lower urinary tract symptoms

Xingqi BAO,Yichen HUANG
DOI: https://doi.org/10.13201/j.issn.1001-1420.2018.01.019
2018-01-01
Journal of Clinical Urology
Abstract:Lower urinary tract symptoms (LUTS) are a series of bladder dysfunctions.It is an important public health problem,which will significantly reduce the life quality of patients in severe cases.Currently,much attention has been paid to research on symptoms during storage and on related afferent nerves,and transient receptor potential vanilloid receptor subtype 1 (TRPV1) is attracting a large number of works at this time.In general,TRPV1 is expressed in peripheral and central nervous system,and studied as a pain target early.Recent many studies have shown that TRPV1 is expressed in the bladder,contributes to LUTS in pathological condition besides regulating the threshold of bladder contraction in physiological condition.Many targeted drugs,including both inhibitors and agonists have been investigated in the clinical study of LUTS.We review the above researches on the association between TRPV1 and LUTS in order to serve for the basic and clinical works of LUTS treatment.
What problem does this paper attempt to address?